Daphne Atlas

This inventor holds 11 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Oneday-Biotech and Pharma Ltd., Teva Pharmaceutical Industries Limited. Active years: 1994-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daphne Atlas. Retrieved from https://idiyas.com/inventor/daphne-atlas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 63.6

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 169(Granted Patents)

Location History:

Neve Granot, IL (1994 - 1997)
Jerusalem, IL (1999 - 2017)

Company Filing History:

8 out of 916

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

patents

3 out of 4

Oneday-Biotech and Pharma Ltd.

patents

3 out of 505

Teva Pharmaceutical Industries Limited

6. 2 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2017

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9617301 - Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof (2017-04-11),

2. 9034824 - Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof (2015-05-19),

3. 8802635 - Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof (2014-08-12),

4. 8530407 - Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress (2013-09-10),

5. 8048926 - L-DOPA amide derivatives and uses thereof (2011-11-01),

6. 6420429 - Brain targeted low molecular weight hydrophobic antioxidant compounds (2002-07-16),

7. 6369106 - Treatment of ischemic brain injuries with brain targeted anti oxidant compounds (2002-04-09),

8. 5874468 - Brain targeted low molecular weight hydrophobic antioxidant compounds (1999-02-23),

9. 5607969 - L-DOPA ethyl ester to treat Parkinson's disease (1997-03-04),

10. 5525631 - Compositions of the ethyl ester of L-DOPA (1996-06-11),

11. 5354885 - Process for preparing ethyl ester of L-DOPA (1994-10-11),

Title: The Innovative Contributions of Daphne Atlas

Introduction

Daphne Atlas is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of biochemistry, particularly in the development of compounds with antioxidant, anti-inflammatory, anti-radiation, and metal chelating properties. With a total of 11 patents to her name, her work has implications in both clinical and cosmetic applications.

Latest Patents

Among her latest patents, Daphne has developed potent compounds that exhibit combined antioxidant, anti-inflammatory, anti-radiation, and metal chelating properties. These innovations include short peptides that possess these beneficial properties, along with methods and uses for these peptides in various applications. Her research continues to push the boundaries of what is possible in the realm of health and wellness.

Career Highlights

Daphne has worked with notable organizations such as Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Teva Pharmaceutical Industries Limited. Her experience in these esteemed institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Daphne has collaborated with esteemed colleagues, including Eldad Melamed and Isaac Milman. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Daphne Atlas stands out as an influential inventor whose work in developing innovative compounds has the potential to transform clinical and cosmetic applications. Her contributions continue to inspire advancements in biochemistry and health sciences.

Profile summary based on public USPTO records.